BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9111819)

  • 21. Prevalence of human papilloma virus type 5 DNA in lesional and non-lesional skin scales of Italian plaque-type psoriatic patients: association with disease severity.
    Prignano G; Ferraro C; Mussi A; Stivali F; Trento E; Bordignon V; Crescimbeni E; Salvati G; Degener AM; Ameglio F
    Clin Microbiol Infect; 2005 Jan; 11(1):47-51. PubMed ID: 15649303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated serum levels of interleukin 21 are associated with disease severity in patients with psoriasis.
    He Z; Jin L; Liu ZF; Hu L; Dang EL; Feng ZZ; Li QJ; Wang G
    Br J Dermatol; 2012 Jul; 167(1):191-3. PubMed ID: 22356196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease.
    Eissa A; Cretu D; Soosaipillai A; Thavaneswaran A; Pellett F; Diamandis A; Cevikbas F; Steinhoff M; Diamandis EP; Gladman D; Chandran V
    Clin Chem Lab Med; 2013 Feb; 51(2):317-25. PubMed ID: 23096109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of cutaneous surface parameters in psoriatic patients.
    Cannavò SP; Guarneri F; Giuffrida R; Aragona E; Guarneri C
    Skin Res Technol; 2017 Feb; 23(1):41-47. PubMed ID: 27270565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study.
    Boehncke S; Salgo R; Garbaraviciene J; Beschmann H; Hardt K; Diehl S; Fichtlscherer S; Thaçi D; Boehncke WH
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1187-93. PubMed ID: 21241371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations.
    Flisiak I; Zaniewski P; Rogalska-Taranta M; Chodynicka B
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):302-7. PubMed ID: 21418334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of serum thymus and activation-regulated chemokine level during biologic therapy for psoriasis: Possibility as a marker reflecting favorable response to anti-interleukin-17A agents.
    Shibuya T; Honma M; Iinuma S; Iwasaki T; Takahashi H; Ishida-Yamamoto A
    J Dermatol; 2018 Jun; 45(6):710-714. PubMed ID: 29655215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI.
    Romaní J; Caixàs A; Ceperuelo-Mallafré V; Carrascosa JM; Ribera M; Rigla M; Vendrell J; Luelmo J
    Arch Dermatol Res; 2013 Mar; 305(2):105-12. PubMed ID: 23242471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated levels of circulating intercellular adhesion molecule-3 (cICAM-3) in Psoriasis.
    Griffiths CE; Boffa MJ; Gallatin WM; Martin S
    Acta Derm Venereol; 1996 Jan; 76(1):2-5. PubMed ID: 8721479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of serotonin transporter protein correlates with the severity of psoriasis and chronic stress.
    Thorslund K; Amatya B; Dufva AE; Nordlind K
    Arch Dermatol Res; 2013 Mar; 305(2):99-104. PubMed ID: 23161175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between plasmatic levels of vitamin D and PASI score.
    Mattozzi C; Paolino G; Salvi M; Macaluso L; Scarnò M; DE Vita G; Calvieri S; Richetta AG
    G Ital Dermatol Venereol; 2018 Apr; 153(2):155-160. PubMed ID: 29144098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mitogenic effects of sera from psoriatic subjects on normal dermal fibroblasts: an absence of correlation with the clinical activity of psoriasis.
    Laubscher TA; Harris N; Chalton DO
    Br J Dermatol; 1991 Feb; 124(2):163-7. PubMed ID: 2003999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of interleukin-8, tumor necrosis factor-α and γ-interferon in Egyptian psoriatic patients and correlation with disease severity.
    Abdel-Hamid MF; Aly DG; Saad NE; Emam HM; Ayoub DF
    J Dermatol; 2011 May; 38(5):442-6. PubMed ID: 21352285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble intercellular adhesion molecule-1 and procollagen III peptide are reliable markers of disease severity in psoriasis.
    Ameglio F; Bonifati C; Carducci M; Alemanno L; Sacerdoti G; Fazio M
    Acta Derm Venereol Suppl (Stockh); 1994; 186():19-20. PubMed ID: 7915482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire.
    Barrea L; Macchia PE; Tarantino G; Di Somma C; Pane E; Balato N; Napolitano M; Colao A; Savastano S
    J Transl Med; 2015 Sep; 13():303. PubMed ID: 26376719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast Growth Factor 23 and Placental Growth Factor in Patients with Psoriasis and their Relation to Disease Severity.
    Okan G; Baki AM; Yorulmaz E; Doğru-Abbasoğlu S; Vural P
    Ann Clin Lab Sci; 2016; 46(2):174-9. PubMed ID: 27098624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of serum uric acid levels in psoriasis vulgaris.
    Yilmaz E; Tamer E; Artüz F; Külcü Çakmak S; Köktürk F
    Turk J Med Sci; 2017 Apr; 47(2):531-534. PubMed ID: 28425242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of tumor necrosis factor-alpha, soluble intercellular adhesion molecule-1, soluble vascular cell adhesion molecule-1, and soluble interleukin-1 receptor antagonist in patients with thyroid eye disease undergoing treatment with somatostatin analogues.
    Krassas GE; Pontikides N; Doukidis D; Heufelder G; Heufelder AE
    Thyroid; 2001 Dec; 11(12):1115-22. PubMed ID: 12186498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.